NCT05888532View on ClinicalTrials.gov

64Cu-GRIP B in Patients With Advanced Malignancies

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

May 25, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

January 31, 2027

Conditions
Prostate CancerRenal CancerUrethral CancerAdvanced Solid TumorMetastatic Castration-resistant Prostate CancerSolid Tumor, Adult
Interventions
DRUG

Copper-64 labeled Granzyme B (64Cu-GRIP B)

Given IV prior to imaging

PROCEDURE

Positron Emission Tomography (PET)

Imaging procedure

Trial Locations (1)

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

U.S. Army Medical Research Acquisition Activity

FED

lead

Rahul Aggarwal

OTHER